Back to UBS Group AG UBS Group AG

ZBIOZBIO
7 quarters

Position history for UBS Group AGUBS Group AG's holdings in ZENAS BIOPHARMA INC

UBS Group AG holds 367,405 shares of ZBIO (ZENAS BIOPHARMA INC), worth $7.2M as of 2026-Q1. The position was increased (+428.7% shares). ZBIO represents 0.0% of UBS Group AG's portfolio.

Current Value

$7.2M

Current Shares

367,405

Total Value Change

+$7.2M

Total Shares Change

+367,346

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
367,405
+428.7%
$7.2M0.0%$25.18
44
2025-Q4
Increased
69,495
+95.8%
$2.5M0.0%$36.58
42
2025-Q3
Increased
35,492
+46.3%
$787,9220.0%$20.57
34
2025-Q2
Increased
24,263
+16.9%
$235,1080.0%$9.58
18
2025-Q1
Decreased
20,765
-84.2%
$164,0440.0%$8.17
0
2024-Q4
Increased
131,665
+2231x
$1.1M0.0%$8.99
41
2024-Q3
New
59
-
$9980.0%$17.14
17

Other major holders of ZBIO: FMR LLC, FEDERATED HERMES, INC., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used